Oral-ATO for TP53-mutated Myeloid Malignancies

Clinical trial NCT06778187 · RECRUITING

Trial details

NCT number: NCT06778187
Sponsor: The University of Hong Kong
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Neoplasm Chronic Myelomonocytic Leukemia TP53 Gene Mutation Arsenic Trioxide

Start date: 2025-02-07
Primary completion: 2027-02-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.